FibroGen (FGEN) Misses Q3 EPS by 325c

FibroGen (NASDAQ: FGEN) reported Q3 EPS of ($3.25). Revenue for the quarter came in at $1.1 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Bessent: We Make A Market Buying Older Bonds
• Exclusive: J&J Snack Foods CEO sees a leaner business set up to return to growth
• Jefferies: 'we can still see at least a +25-50% stock move if SRPT shows competitive/superior 6-month splicing/vHOT data'